Overview
  • Replikins, Ltd. develops and markets novel forecasting tools and synthetic vaccines to fight virulent rapidly replicating diseases including bird flu, malaria, and HIV. The company's predictive products and vaccines in development are based upon the company's discovery of Replikins, a new group of peptides related to the rapid replication function in viral and other diseases. The company has designed unique products to predict the emergence of virulent strains of particular diseases (FluForecast™) and is designing synthetic vaccines specifically tailored to combat a given strain and against shared properties of several strains (Syntope™ vaccines). The company is partnering with governments and the private sector in providing predictive tools and vaccines in furtherance of the public health initiative to prevent and combat epidemics.


  • To date, no means has been available to predict if and what strain of a given organism will threaten a human or animal population. It has not been possible to design appropriate vaccines, produce, test and administer them before an epidemic has emerged and caused damage to a population. Replikins, Ltd's predictive FluForecast™ product enables advance warning of potential epidemics. The company's understanding of the protein chemistry of rapid replication has also enabled it to design synthetic vaccines specifically tailored to destroy or restrict replication of the targeted virus strains before an outbreak. The vaccines are currently in development.


  • The company's vaccines and predictive tools are based on the company's discovery of a new group of peptides responsible for rapid replication called Replikins, whose increase in concentration in virus or other organism proteins (Replikin Count™ peptide quantities) is associated with rapid replication. By tracing the Replikin Count™ peptide quantities, epidemics can be predicted earlier (one to three years in advance) and it is the company's goal to design, test and prepare for administration synthetic vaccines prior to the outbreak of those epidemics
 
 
Privacy Policy | Legal Info